SEC Filing Summary for Actinium Pharmaceuticals, Inc.

This filing details changes in beneficial ownership for Steffen Heeger, Chief Medical Officer of Actinium Pharmaceuticals, Inc. Heeger holds 153,868 shares of Common Stock, represented by restricted stock units (RSUs) that vest fully on September 2, 2029. Additionally, he holds stock options to purchase 250,000 shares of Common Stock at an exercise price of $1.15. These options have an expiration date of May 28, 2036. A portion of the options, 28%, vest on May 28, 2027, with the remainder vesting in 36 equal monthly tranches thereafter. The filing indicates direct ownership of these securities.